Profil
Hugo Petit currently works at Theducation AB, as Director from 2014, Falck Igel AB, as Director, Abilia Holding AG, as Director, Petit Consulting AB, as Director, Catator AB, as Director, Lipigon Pharmaceuticals AB, as Chief Financial Officer from 2023, Zwipe AS, as Chief Financial Officer & Head-Human Resource from 2024, and XNK Therapeutics AB, as Chief Financial Officer.
Mr. Petit also formerly worked at AdderaCare AB, as Chief Executive Officer, Cardiolex Medical AB, as Director, Sweden Organic AB, as Information & Expertise Director, Säljuniversitetet I Sverige AB, as Information & Expertise Director, Modina Kompetens AB, as Information Director, Modina Personal AB, as Information & Expertise Director, MedCap AB, as Chief Financial Officer from 2014 to 2018, 3 nine AB, as Head-Finance & Production, OxThera AB, as Chief Financial Officer, MedCap AB (Private Equity), as Chief Financial Officer from 2014 to 2018, Fyndiq AB, as Chief Financial Officer, and Circulose AB, as Chief Financial Officer from 2021 to 2022.
Mr. Petit received his Masters Business Admin degree from the University of Uppsala and graduate degree from Royal Military Academy.
Postes actifs de Hugo Petit
| Sociétés | Poste | Début |
|---|---|---|
| LIPIGON PHARMACEUTICALS AB | Directeur Financier/CFO | 01/01/2023 |
| ZWIPE | Directeur Financier/CFO | 01/02/2024 |
Abilia Holding AG | Directeur/Membre du Conseil | - |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Directeur des opérations | - |
Petit Consulting AB | Directeur/Membre du Conseil | - |
Theducation AB
Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services | Directeur/Membre du Conseil | 01/06/2014 |
Falck Igel AB | Directeur/Membre du Conseil | - |
Catator AB
Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design | Directeur/Membre du Conseil | - |
Anciens postes connus de Hugo Petit
| Sociétés | Poste | Fin |
|---|---|---|
| ADDERACARE AB | Directeur Général | 04/01/2023 |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Hugo Petit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
MedCap AB
MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiolex Medical AB
Cardiolex Medical AB Medical SpecialtiesHealth Technology Develops and markets the vacuum ECG for fixation of ECG electrodes | Health Technology |
3 nine AB
3 nine AB Industrial MachineryProducer Manufacturing Develops solutions for the purification and processing of air | Producer Manufacturing |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
MedCap AB (Private Equity)
MedCap AB (Private Equity) Investment ManagersFinance MedCap concentrates on investments in the Nordic region as well as in Europe, with a short- or medium-term outlook. The firm targets debt-free SMEs with substantial development potential and valued up to SEK 200 million, or having SEK 50 to 200 million in turnover. They target annual returns on each investment of at least 20 percent. MedCap typically acquires majority stakes in their portfolio companies. They may also take minority stakes, with a minimum of 20 percent. Their portfolio is generally composed of eight to ten firms. They are active investors. They provide experience and access to networks along with expansion capital when necessary. Their targeted investment horizon is five to seven years. MedCap also aims to consolidate the life science market in the Nordic region. To this end, they consider merging ownership to form more robust organizations, as well as collaborating on sales, and product development. They have invested in areas such as technical aids for persons with disabilities, healthcare technologies, systems for vacuum electrodes for ECG, micro-technology and miniaturized separation science, tissue engineering to develop functional substitutes for damaged tissues, and pharmacological solutions for treatment of nicotine addiction. | Finance |
Theducation AB
Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services | Commercial Services |
Sweden Organic AB
Sweden Organic AB Food DistributorsDistribution Services Wholesales non-alcoholic and alcoholic beverages | Distribution Services |
Royal Military Academy
Royal Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
Zwipe AS
Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards | Electronic Technology |
Fyndiq AB
Fyndiq AB Specialty StoresRetail Trade Operates an online marketplace for bargain products | Retail Trade |
Säljuniversitetet I Sverige AB | |
Catator AB
Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design | Process Industries |
Falck Igel AB | |
Modina Kompetens AB | |
Modina Personal AB | |
AdderaCare AB
AdderaCare AB Medical SpecialtiesHealth Technology Operates as holding company whose subsidiaries manufactures sensory stimulating products | Health Technology |
Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
Abilia Holding AG | |
Re:NewCell AB
Re:NewCell AB TextilesProcess Industries Manufactures regenerate textile fibers through used & waste clothes | Process Industries |
Petit Consulting AB |
















